Researchers identified a genetic variant that significantly lowers the risk of Alzheimer’s disease by up to 70%, potentially benefiting hundreds of thousands in the U.S. The variant, found in the fibronectin gene involved in the blood-brain barrier's function, aids in preventing amyloid accumulation in the brain, a hallmark of Alzheimer’s.